Home/Captura Biopharma/Michael B. Geranen
MB

Michael B. Geranen

CEO, Co-Founder

Captura Biopharma

Captura Biopharma Pipeline

DrugIndicationPhase
C2E2Treatment of internal radioactive contamination (e.g., from nuclear accidents, radiological incidents)Pre-clinical